Browsing Over 414 Presentations
Sort By
Daiichi-Sankyo - Industry Satellite Symposium: Targeting HER driven breast cancer - Emerging and future options (ID 36)
Industry Satellite Symposium
Welcome & introduction (ID 827)
Lecture Time
13:00 - 13:05
Speakers
- Fabrice André (Villejuif, France)
Location
Vienna Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
03.05.2019
Time
13:00 - 14:00
Daiichi-Sankyo - Industry Satellite Symposium: Targeting HER driven breast cancer - Emerging and future options (ID 36)
Industry Satellite Symposium
Current progress in HER2 positive metastatic breast cancer (ID 828)
Lecture Time
13:05 - 13:20
Speakers
- Hope S. Rugo (San Francisco, CA, United States of America)
Location
Vienna Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
03.05.2019
Time
13:00 - 14:00
Daiichi-Sankyo - Industry Satellite Symposium: Targeting HER driven breast cancer - Emerging and future options (ID 36)
Industry Satellite Symposium
Evolution of HER2-targeted therapies: The role of antibody drug conjugates (ID 829)
Lecture Time
13:20 - 13:35
Speakers
- Fabrice André (Villejuif, France)
Location
Vienna Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
03.05.2019
Time
13:00 - 14:00
Daiichi-Sankyo - Industry Satellite Symposium: Targeting HER driven breast cancer - Emerging and future options (ID 36)
Industry Satellite Symposium
The emerging treatment paradigm for HER driven breast cancer (ID 830)
Lecture Time
13:35 - 13:50
Speakers
- Javier Cortes (Barcelona, Spain)
Location
Vienna Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
03.05.2019
Time
13:00 - 14:00
Daiichi-Sankyo - Industry Satellite Symposium: Targeting HER driven breast cancer - Emerging and future options (ID 36)
Industry Satellite Symposium
Q&A with speaker panel (ID 831)
Lecture Time
13:50 - 14:00
Speakers
- Fabrice André (Villejuif, France)
- Javier Cortes (Barcelona, Spain)
- Hope S. Rugo (San Francisco, CA, United States of America)
Location
Vienna Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
03.05.2019
Time
13:00 - 14:00
Early breast cancer: HER2 positive (ID 4)
Educational session
Neoadjuvant therapy in ER+ positive disease (ID 2)
Lecture Time
14:30 - 14:50
Speakers
- Jens Huober (Ulm, Germany)
Session Name
Location
Maritim Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
02.05.2019
Time
14:30 - 16:00
Early breast cancer: HER2 positive (ID 4)
Educational session
Adjuvant therapy (ID 3)
Lecture Time
14:50 - 15:10
Speakers
- Edith A. Perez (Jacksonville, United States of America)
Session Name
Location
Maritim Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
02.05.2019
Time
14:30 - 16:00
Early breast cancer: HER2 positive (ID 4)
Educational session
Neoadjuvant therapy in ER-negative disease (ID 4)
Lecture Time
15:10 - 15:30
Speakers
- Aleix Prat (Barcelona, Spain)
Session Name
Location
Maritim Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
02.05.2019
Time
14:30 - 16:00
Early breast cancer: HER2 positive (ID 4)
Educational session
Extended adjuvant therapy (ID 5)
Lecture Time
15:30 - 15:50
Speakers
- Miguel Martín (Madrid, Spain)
Session Name
Location
Maritim Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
02.05.2019
Time
14:30 - 16:00
Early breast cancer: HER2 positive (ID 4)
Educational session
Q&A (ID 6)
Lecture Time
15:50 - 16:00
Session Name
Location
Maritim Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
02.05.2019
Time
14:30 - 16:00
Early breast cancer: HER2-/HR positive (ID 6)
Educational session
Genomics of intrinsic endocrine resistance, new insights and therapeutic hypotheses (ID 13)
Lecture Time
16:50 - 17:10
Speakers
- Charles M. Perou (Chapel Hill, NC, United States of America)
Session Name
Location
Maritim Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
02.05.2019
Time
16:30 - 18:00
Early breast cancer: HER2-/HR positive (ID 6)
Educational session
Late relapse and duration of therapy, where are we? (ID 14)
Lecture Time
17:10 - 17:30
Speakers
- Mitchell Dowsett (London, United Kingdom)
Session Name
Location
Maritim Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
02.05.2019
Time
16:30 - 18:00